18F-Fluorocholine PET for Parathyroid Adenomas
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
How does 18F-Fluorocholine PET differ from other treatments for parathyroid adenomas?
What data supports the effectiveness of the treatment 18F-Fluorocholine for parathyroid adenomas?
Research shows that 18F-Fluorocholine PET imaging is helpful in accurately locating parathyroid adenomas, especially when other imaging methods like ultrasound and scintigraphy give unclear results. This can be particularly useful for planning surgery in patients with primary hyperparathyroidism, making the treatment more effective.16789
Who Is on the Research Team?
Thomas A. Hope, MD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals aged 13 or older with biochemically proven hyperparathyroidism who need surgery. Participants must be able to understand and sign a consent form. Pregnant individuals or those unlikely to follow study procedures are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants receive a single dose of 18F-Fluorocholine and undergo a PET imaging study
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- 18F-Fluorocholine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thomas Hope
Lead Sponsor